American Society for Microbiology, Antimicrobial Agents and Chemotherapy, 7(63), 2019
DOI: 10.1128/aac.02651-18
Full text: Download
Mycobacterium abscessus is responsible for difficult-to-treat chronic pulmonary infections in humans. Current regimens, including parenteral administrations of cefoxitin (FOX) in combination with amikacin and clarithromycin, raise compliance problems and are frequently associated with high failure and development of resistance.